Connect with us

Press Blog

HP Accelerating Life Science and Pharma Research with New D100 Single Cell Dispenser

March 01, 2023

HP Inc., a leading player in microfluidics technologies, announced the U.S. launch of its new D100 Single Cell Dispenser. Using HP’s proven approach to inkjet-based microfluidics, the D100 Single Cell Dispenser democratizes single-cell analysis with high occupancy, viability, and precision, facilitating the acceleration of discovery of therapeutics and helping advance life science and pharma research around the world.
“As an inkjet leader, HP has decades of experience in microfluidics,“ said Philippe Lesage, VP and GM, Specialty Printing & Technology Solutions at HP. “This provides us with the foundation to handle various types of fluids at a micro-level beyond our well-known HP inks and extend into new and exciting domains, including dispensing and cell isolation for drug discovery research, product coding and marking, and late-stage packaging. Applying our expertise and scalability in these areas is a key driver of innovation for the business. While leading pharma companies and research institutions around the world are already using our microfluidics technology for dose response studies, we are excited to bring this new single cell isolation solution to market, and we expect this will accelerate the transformation of the industry’s approach to drug and vaccine research and development.”
HP’s simple but powerful software combines cell isolation and reagent dispense for workflow miniaturization. Researchers can dispense single cells, as well as precisely dispense picoliter through microliter volumes of reagents in an easy-to-navigate user interface with real time reporting built in.

In an industry estimated to reach nearly $61 billion by 2030, the field of possibility for biotech is growing, including the number of single cell research applications primed for microfluidics based on inkjet technology. Improved and accelerated research in proteomics, genomics, cell line development and cell and gene therapy are expected to change the way diseases are detected and push us into a new era of more personalized and powerful healthcare.
The new HP D100 Single Cell Dispenser is currently available in the U.S. with future plans to roll out globally.
Learn more here on how to advance your research with the new HP D100 Single Cell Dispenser.


About HP

Media Contact

HP Inc. (NYSE:HPQ) is a global technology leader and creator of solutions that enable people to bring their ideas to life and connect to the things that matter most. Operating in more than 170 countries, HP delivers a wide range of innovative and sustainable devices, services and subscriptions for personal computing, printing, 3D printing, hybrid work, gaming, and more. For more information, please visit:


HP Media relations


HP Press Center